Department of Otolaryngology-Head and Neck Surgery, Amsterdam UMC, Location VUmc, Amsterdam, The Netherlands.
Department of Otolaryngology-Head and Neck Surgery, Christchurch Public Hospital, Christchurch, New Zealand.
Eur Arch Otorhinolaryngol. 2024 Sep;281(9):4529-4539. doi: 10.1007/s00405-024-08661-6. Epub 2024 May 7.
To systematically review current literature on the treatment of lymphatic malformations (LMs) of the head and neck to guide treatment strategy.
A systematic review and meta-analysis of literature until 16 November 2021 was performed on treatments of LMs in the head and neck.
Out of 9044 articles, 54 studies were eligible for inclusion with 26 studies providing detailed participant data. A total number of 1573 patients with a mean age of 21.22 months were analysed. Comparative meta-analysis did not reveal significant differences two proportions of volume reduction (≥ 50% and 100%) between sclerotherapy and surgical treatment. Regression demonstrated that positive predictors for volume reduction were surgery 17 (95% CI 0.26-34; p = 0.047) and treatment of macrocystic lesions 19 (95% CI 5.5-32; p = 0.006). Treatment of mixed lesions also demonstrated a trend towards achieving a greater volume reduction (p = 0.052). A higher de Serres stage of the lesion had a negative effect on the amount of volume reduction - 3.7 (95% CI - 7.0 to - 0.35; p = 0.030).
This comprehensive meta-analysis demonstrated no significant difference in volume reduction between various treatment modalities at study level. However, individual patient data indicated that surgery and larger cyst types are associated with a significant higher percentage of volume reduction, whereas a higher de Serres stage negatively impacted the amount of volume reduction. These findings can be used for patient counseling and treatment planning based on cyst type and de Serres stage. However volume reduction constitutes just one objective within a more complex treatment spectrum.
系统回顾目前关于头颈部淋巴管畸形(LM)治疗的文献,以指导治疗策略。
对截至 2021 年 11 月 16 日头颈部 LM 治疗的文献进行系统回顾和荟萃分析。
在 9044 篇文章中,有 54 项研究符合纳入标准,其中 26 项研究提供了详细的参与者数据。共分析了 1573 名平均年龄为 21.22 个月的患者。荟萃分析比较未显示硬化治疗和手术治疗在体积减少比例(≥50%和 100%)上存在显著差异。回归分析表明,手术(95%CI 0.26-34;p=0.047)和大囊型病变治疗(95%CI 5.5-32;p=0.006)是体积减少的阳性预测因素。混合病变的治疗也显示出更大体积减少的趋势(p=0.052)。病变的更高级别的 de Serres 对体积减少量有负面影响 -3.7(95%CI -7.0 至 -0.35;p=0.030)。
这项综合荟萃分析表明,在研究水平上,各种治疗方法在体积减少方面没有显著差异。然而,个体患者的数据表明,手术和更大的囊肿类型与体积减少的百分比显著增加相关,而更高的 de Serres 级别的病变则对体积减少量产生负面影响。这些发现可用于基于囊肿类型和 de Serres 级别的患者咨询和治疗计划。然而,体积减少只是更复杂治疗谱中的一个目标。